uMotif
Bruce Hellman

Bruce Hellman

Chief Patient Officer & Co-Founder

Bruce brings his passion for advancing patient-centricity in clinical trials and technology to his work at uMotif. Bruce co-founded uMotif in 2012, initially inspired to help patients with Parkinson’s Disease track and better manage their condition. As Chief Patient Officer, he applies a patient-centric lens to guide the continued evolution of uMotif’s modern eCOA/ePRO solution and enable unrivaled engagement.

Bruce began his career working in clinical trials at British Biotech before joining the UK Civil Service Fast Stream in the Department for Culture, Media and Sport.

Enthusiastic about sharing his vision for expanding patient-centricity in clinical trial development and technology, Bruce speaks regularly at conferences, participates in academic research and working groups, and contributes frequently to publications, including Advanced Clinical Trials and Clinical Research News.

Bruce, who holds an MBA from Imperial College Business School, has been recognized in the PharmaVoice 100 as one of the most innovative entrepreneurs in life sciences and received a Cisco BIG award.

An avid athlete, Bruce is a three-time Ironman finisher and Head Coach of the Teddington Athletic Under 12s Sharks football team.

Back to leadership

Related Resources

We Need a People-First Approach to Clinical Trial Technology
uMotif Shaping New Patient-Centric Design in Clinical Trials